J-DISCOVER: DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
J-DISCOVER: DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan
This study is intended to prospectively research the treatment reality and long-term disease control of Type 2 Diabetes Mellitus (T2DM) patients who are initiating 2nd line anti-diabetes treatment in sites across Japan.
This study is a single country, multicenter, observational, prospective, longitudinal cohort study which will include adult patients with documented history of T2DM who are initiating a second line oral or parenteral anti-diabetes mediation after their first line anti-diabetic therapy in real world setting. The follow-up period is 3 years. Patients will undergo clinical assessments and receive standard medical care as determined by the treating physician. Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the study.
Inclusion Criteria:
Exclusion Criteria:
Anzai, Aichi-ken, Japan
Komatsu, Aichi-ken, Japan
Kurate-gun, Fukuoka, Japan
Oguri, Fukuoka, Japan
Kanra-gun, Gunma, Japan
Kitakatsuragi-gun, Nara, Japan
Ikuno-ku, Osaka, Japan
Sennan-gun, Osaka, Japan
Nishimatuura, Saga-ken, Japan
Kouka, Shiga, Japan
Shimotsuga-gun, Tochigi, Japan
Edogawa-ku, Tokyo, Japan
Nerima-ku, Tokyo, Japan
Shinagawa-ku, Tokyo, Japan